The regulation of vascular endothelial growth factor by hypoxia and prostaglandin F 2α during human endometrial repair

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 8, 2011, Pages 2475-2483

  Maybin, Jacqueline A ^a   Hirani, Nikhil ^b   Brown, Pamela ^b   Jabbour, Henry N ^b   Critchley, Hilary O D ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PROGESTERONE; PROSTAGLANDIN F2 ALPHA; VASCULOTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ENDOMETRIUM CELL; EPITHELIUM CELL; EXPLANT; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IN VITRO STUDY; MENSTRUAL CYCLE; MENSTRUATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ASSAY; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STROMA CELL; TISSUE REPAIR;

ADULT; ANOXIA; BIOPSY; CELLS, CULTURED; CYCLOOXYGENASE INHIBITORS; DINOPROST; ENDOMETRIUM; ESTRADIOL; FEMALE; HORMONE ANTAGONISTS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INDOMETHACIN; MENSTRUAL CYCLE; MIDDLE AGED; MIFEPRISTONE; PROGESTERONE; REGENERATION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 79961219919     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2010-2971     Document Type: Article

References (39)

1. Critchley HO, Jones RL, Lea RG, Drudy TA, Kelly RW, Williams AR, Baird DT 1999 Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy. J Clin Endocrinol Metab 84:240-248 (Pubitemid 29036709)
2. Maybin J, Critchley H 2009 Repair and regeneration of the human endometrium. Expert Rev Obstet Gynecol 4:283-298
3. Prentice A 1999 Health care implications of dysfunctional uterine bleeding. Baillieres Best Pract Res Clin Obstet Gynaecol 13:181-188 (Pubitemid 29353804)
4. Cromwell DA, Mahmood TA, Templeton A, van der Meulen JH 2009 Surgery for menorrhagia within English regions: variation in rates of endometrial ablation and hysterectomy. BJOG 116:1373-1379
5. Ferrara N 2004 Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581-611 (Pubitemid 39099316)
6. Carmeliet P 2005 VEGF as a key mediator of angiogenesis in cancer. Oncology 69(Suppl 3):4-10 (Pubitemid 41680947)
7. Smith SK 2001 Regulation of angiogenesis in the endometrium. Trends Endocrinol Metab 12:147-151 (Pubitemid 33713554)
8. Blum S, Issbrüker K, Willuweit A, Hehlgans S, Lucerna M, Mechtcheriakova D, Walsh K, von der Ahe D, Hofer E, Clauss M 2001 An inhibitory role of the phosphatidylinositol 3-kinase-signaling pathway in vascular endothelial growth factor-induced tissue factor expression. J Biol Chem 276:33428-33434
9. Fan X, Krieg S, Kuo CJ, Wiegand SJ, Rabinovitch M, Druzin ML, Brenner RM, Giudice LC, Nayak NR 2008 VEGF blockade inhibits angiogenesis and reepithelialization of endometrium. FASEB J 22:3571-3580
10. Nayak NR, Critchley HO, Slayden OD, Menrad A, Chwalisz K, Baird DT, Brenner RM 2000 Progesterone withdrawal up-regulates vascular endothelial growth factor receptor type 2 in the superficial zone stroma of the human and macaque endometrium: potential relevance to menstruation. J Clin Endocrinol Metab 85:3442-3452
11. Punyadeera C, Thijssen VL, Tchaikovski S, Kamps R, Delvoux B, Dunselman GA, de Goeij AF, Griffioen AW, Groothuis PG 2006 Expression and regulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium. Mol Hum Reprod 12:367-375 (Pubitemid 43985607)
12. Malik S, Day K, Perrault I, Charnock-Jones DS, Smith SK 2006 Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-α in menstrual endometrium and effluent in women with menorrhagia. Hum Reprod 21:2158-2166 (Pubitemid 44288097)
13. Kaitu'u-Lino TJ, Morison NB, Salamonsen LA 2007 Estrogen is not essential for full endometrial restoration after breakdown: lessons from a mouse model. Endocrinology 148:5105-5111 (Pubitemid 47481555)
14. Sugino N, Karube-Harada A, Taketani T, Sakata A, Nakamura Y 2004 Withdrawal of ovarian steroids stimulates prostaglandin F2α production through nuclear factor-κB activation via oxygen radicals in human endometrial stromal cells: potential relevance to menstruation. J Reprod Dev 50:215-225 (Pubitemid 40631821)
15. Markee JE 1940 Menstruation in intraocular transplants in the rhesus monkey. Contr Embryol Carnegie Instn 28:219-308
16. Fukuda R, Kelly B, Semenza GL 2003 Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res 63:2330-2334 (Pubitemid 36538645)
17. Higgins DF, Biju MP, Akai Y, Wutz A, Johnson RS, Haase VH 2004 Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol 287:F1223-F1232 (Pubitemid 39507231)
18. Semenza GL 2000 HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88:1474-1480 (Pubitemid 30217451)
19. Critchley HO, Osei J, Henderson TA, Boswell L, Sales KJ, Jabbour HN, Hirani N 2006 Hypoxia-inducible factor-1α expression in human endometrium and its regulation by prostaglandin E-series prostanoid receptor 2 (EP2). Endocrinology 147:744-753 (Pubitemid 43112990)
20. Noyes RW, Hertig AT, Rock J 1950 Dating the endometrial biopsy. Fertil Steril 1:3-25
21. Sales KJ, Maudsley S, Jabbour HN 2004 Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3′,5′-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways. Mol Endocrinol 18:1533-1545 (Pubitemid 38692189)
22. Kane N, Jones M, Brosens JJ, Saunders PT, Kelly RW, Critchley HO 2008 Transforming growth factor-β1 attenuates expression of both the progesterone receptor and dickkopf in differentiated human endometrial stromal cells. Mol Endocrinol 22:716-728 (Pubitemid 351397797)
23. Mizukami Y, Li J, Zhang X, Zimmer MA, Iliopoulos O, Chung DC 2004 Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer. Cancer Res 64:1765-1772 (Pubitemid 38428700)
24. Sowter HM, Raval RR, Moore JW, Ratcliffe PJ, Harris AL 2003 Predominant role of hypoxia-inducible transcription factor (Hif)-1α versus Hif-2α in regulation of the transcriptional response to hypoxia. Cancer Res 63:6130-6134 (Pubitemid 37255150)
25. 2α in epithelial cell proliferation. J Clin Endocrinol Metab 88:1825-1832
26. 2 and EP2/EP4 receptors in human nonpregnant endometrium across the menstrual cycle. J Clin Endocrinol Metab 86:4453-4459
27. Critchley HO, Wang H, Kelly RW, Gebbie AE, Glasier AF 1998 Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Hum Reprod 13:1210-1217 (Pubitemid 28279172)
28. Ludwig H, Spornitz UM 1991 Microarchitecture of the human endometrium by scanning electron microscopy: menstrual desquamation and remodeling. Ann NY Acad Sci 622:28-46
29. Nayak NR, Brenner RM 2002 Vascular proliferation and vascular endothelial growth factor expression in the rhesus macaque endometrium. J Clin Endocrinol Metab 87:1845-1855 (Pubitemid 34615279)
30. Zhang L, Scott PA, Turley H, Leek R, Lewis CE, Gatter KC, Harris AL, Mackenzie IZ, Rees MC, Bicknell R 1998 Validation of antivascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium. J Pathol 185:402-408 (Pubitemid 28355973)
31. Charnock-Jones DS, Sharkey AM, Rajput-Williams J, Burch D, Schofield JP, Fountain SA, Boocock CA, Smith SK 1993 Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod 48:1120-1128 (Pubitemid 23107814)
32. Sharkey AM, Day K, McPherson A, Malik S, Licence D, Smith SK, Charnock-Jones DS 2000 Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. J Clin Endocrinol Metab 85:402-409 (Pubitemid 32268843)
33. Sales KJ, List T, Boddy SC, Williams AR, Anderson RA, Naor Z, Jabbour HN 2005 A novel angiogenic role for prostaglandin F2α-FP receptor interaction in human endometrial adenocarcinomas. Cancer Res 65:7707-7716 (Pubitemid 41297245)
34. Critchley HO, Kelly RW, Baird DT, Brenner RM 2006 Regulation of human endometrial function: mechanisms relevant to uterine bleeding. Reprod Biol Endocrinol 4(Suppl 1):S5
35. Hickey M, Carati C, Manconi F, Gannon BJ, Dwarte D, Fraser IS 2000 The measurement of endometrial perfusion in norplant users: a pilot study. Hum Reprod 15:1086-1091 (Pubitemid 30251306)
36. Hänze J, Weissmann N, Grimminger F, Seeger W, Rose F 2007 Cellular and molecular mechanisms of hypoxia-inducible factor driven vascular remodeling. Thromb Haemost 97:774-787 (Pubitemid 46779962)
37. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL 1996 Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613 (Pubitemid 26272112)
38. Smith SK, Abel MH, Kelly RW, Baird DT 1981 Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol 88:434-442 (Pubitemid 11113117)
39. Smith OP, Jabbour HN, Critchley HO 2007 Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation. Hum Reprod 22:1450-1456 (Pubitemid 47062818)